Tacrolimus (FK506): New treatment approach in superantigen-associated diseases like atopic dermatitis?
- 1 February 2001
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 107 (2) , 391-392
- https://doi.org/10.1067/mai.2001.112848
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Nuclear Factor of Activated T Cells Transcription Factor Nfatp Controls Superantigen-Induced Lethal ShockThe Journal of Experimental Medicine, 2000
- Induction of corticosteroid insensitivity in human PBMCs by microbial superantigensJournal of Allergy and Clinical Immunology, 2000
- Evidence for a disease-promoting effect of Staphylococcus aureus–derived exotoxins in atopic dermatitisJournal of Allergy and Clinical Immunology, 2000
- Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitisJournal of Allergy and Clinical Immunology, 1999
- Evidence for Superantigen Involvement in Skin Homing of T cells in Atopic DermatitisJournal of Investigative Dermatology, 1999
- Prevalence and role of serum IgE antibodies to the StaphylococcuS aureus–derived superantigens SEA and SEB in children with atopic dermatitisJournal of Allergy and Clinical Immunology, 1999
- A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in childrenJournal of Allergy and Clinical Immunology, 1998
- Topical tacrolimus (FK 506): A new milestone in the management of atopic dermatitisJournal of Allergy and Clinical Immunology, 1998
- A Short-Term Trial of Tacrolimus Ointment for Atopic DermatitisNew England Journal of Medicine, 1997
- Co-operative double-blind trial of an antibiotic/ corticoid combination in impetiginized atopic dermatitisBritish Journal of Dermatology, 1976